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OBJECTIVE — Totesttheeffectsofmonitoringanddiscussingofhealth-relatedqualityoflife
(HRQoL) in adolescents with type 1 diabetes in a multicenter randomized controlled trial.
RESEARCH DESIGN AND METHODS — Four centers were randomly assigned to the
HRQoLintervention(46adolescents)orcontrol(45adolescents)group,withthreeregularvisits
scheduled within 12 months in both groups. In the HRQoL intervention group, HRQoL of
adolescents was assessed using the Pediatric Quality of Life Inventory, and outcomes were
discussed face-to-face during the consultation. The control group received care as usual. Mean
differences between the groups at 12 months in physical and psychosocial well-being (Child
Health Questionnaire [CHQ]-CF87/PF50, Diabetes-Speciﬁc Family Conﬂict Scale, and Center
for Epidemiological Studies Scale for Depression), satisfaction with care (Patients’ Evaluation of
the Quality of Diabetes Care), and A1C were determined, controlling for baseline scores.
RESULTS — MeanscoresontheCHQsubscalesofpsychosocialhealth(P0.001),behavior
(P  0.001), mental health (P  0.001), and family activities (P  0.001) improved in the
HRQoL intervention group, except for adolescents with the highest A1C values. Adolescents in
the HRQoL intervention group reported higher self-esteem (CHQ) at follow-up (P  0.016),
regardless of A1C, and were more satisﬁed with care (P  0.009) than control subjects. No
signiﬁcant differences between the two groups over time were observed in A1C levels.
CONCLUSIONS — Periodic monitoring and discussion of HRQoL in adolescents with dia-
betes is appreciated and has positive effects on their psychosocial well-being, except for those in
poorest control.
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H
ormonal and psychosocial changes
related to puberty can seriously
complicate diabetes regulation. In-
deed, adolescents with type 1 diabetes as
a group display the worst glycemic con-
trol compared with other age-groups
(1,2). From a developmental perspective,
the daily demands of self-regulation can
interfere with adolescents’ normal routines
and friendships, thereby compromising
their emotional and social well-being (3).
Moreover,teenagerstendtogivehighpri-
ority to fulﬁlling their psychosocial needs
here and now rather than taking preven-
tive action to avoid health risks long term
(4). Attaining good health-related quality
of life (HRQoL) as well as strict glycemic
control is a challenge for adolescents with
diabetes, their families, and health care
providers.
Periodic evaluation and discussion of
the adolescents’ HRQoL as an integral
part of diabetes care is recommended to
ensure recognition of the teenagers’ per-
spective, identify psychosocial barriers,
and promote healthy coping (5,6). The
utility of such an approach has not been
tested in pediatric diabetes, but was
shown to be beneﬁcial in pediatric rheu-
matic patients as well as adult diabetes
and cancer patients (7–9). We set out to
test the effects of systematic monitoring
and discussion of HRQoL of adolescents
withtype1diabetesinarandomizedcon-
trolled trial. We hypothesized this would
have a positive effect on the well-being
and satisfaction with care of the adoles-
cents, subsequently improving self-care
and glycemic control.
RESEARCH DESIGN AND
METHODS
Participants in the age range of 13–17
years were recruited from four pediatric
diabetes clinics in the Netherlands. Clin-
ics were selected based on willingness to
participate, number of patients, and sim-
ilar clinical routines. Exclusion criteria
were as follows: diabetes duration 6
months, mental retardation, and not ﬂu-
ent in the Dutch language. The study was
approved by the medical ethical commit-
tees of the participating centers; written
informed consent was obtained from pa-
tients and parents.
Design
After a baseline assessment of demo-
graphics, diabetes duration, and treat-
ment regimen, the four outpatient clinics
wererandomlyassignedtoeitherthecon-
trol or HRQoL intervention group. There
were seven pediatricians in the HRQoL
intervention and six in the control group.
Center rather than patient randomization
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pediatricians’ level. During the 12-month
study period, all adolescents had three
regular appointments at 3-month inter-
val. At each consultation, data were gath-
ered on height, weight, A1C levels, and
treatment regimen.
Power calculations, taking into ac-
count the intercluster correlation (
0.006), indicated that a difference of ﬁve
points in mean well-being (range 0–100
and SD  11) and a difference of 0.5% in
meanA1C(SD1.1)ata5%signiﬁcance
level with 80% power could be detected
with 21 adolescents in each cluster (hos-
pital) and thus 42 in each group.
HRQoL intervention group
TheHRQoLinterventionconsistedoftwo
parts: 1) monitoring the HRQoL right be-
fore the 3-month appointment with the
pediatrician and 2) discussion of the
HRQoL scores with the teenager during
the appointment. The adolescents com-
pleted the Pediatric Quality of Life Inven-
tory (PedsQL) Generic and PedsQL
Diabetes-speciﬁc modules on a computer
before the consultation with their pedia-
trician. The generic module of the
PedsQLcomprisesaPhysicalandPsycho-
social subscale. The latter consists of an
Emotional, Social, and School subscale
(10).
The Diabetes module contains items
on symptoms, treatment barriers, treat-
ment adherence, worries, and communi-
cation (11). A total of 51 questions were
answered on a ﬁve-point Likert scale. The
computer program automatically calcu-
lated the subscale scores of the PedsQL,
between 0 and 100, with higher scores
representing better HRQoL. Reports with
the outcomes of the PedsQL were printed
for the pediatrician and the adolescent to
be discussed during the consultation.
Beforethestudy,pediatricianshadre-
ceivedashorttrainingonhowtointerpret
and discuss HRQoL scores and were of-
feredasmallguidewithinstructionsanda
listoftheindividualitemsofeachPedsQL
subscale as a backup for discussing
PedsQL scores.
Pediatricians were instructed to start
with discussing Generic PedsQL scores,
with Dutch norm scores as reference, and
respectfully invite the adolescent to com-
ment and discuss the outcomes. Thereaf-
ter, the Diabetes-speciﬁc subscales of the
PedsQL were discussed, exploring possi-
ble solutions and actions. Pediatricians
were asked to ﬁll out a checklist to docu-
ment topics and decisions. At the follow-
ing (second and third) appointments, the
pediatrician and adolescent could track
and discuss changes in PedsQL scores
over time (if any).
Patientsandparentswereinformedat
the start of the study that parents were
welcome to join the consultation during
the last 10 min and of course could be
present during the whole consultation if
so wished by patient and parent.
Control group
The adolescents received care as usual in
the control group. To control for answer-
ing questions on the computer before the
consultation, adolescents completed a
lifestyle questionnaire instead of an
HRQoL questionnaire on the computer,
with items on eating, drinking, leisure ac-
tivities,sports,andfriends.Patientsinthe
controlgroupwereinformedthattheout-
comesofthismeasurementwerenottobe
discussed during the consultation or
thereafter.
Outcome measures
Baseline and follow-up assessment took
place separate from the clinical appoint-
ments.Beforetheﬁrstappointment,base-
line measures were assessed by sending
adolescents and parents a questionnaire
booklet on physical and psychosocial
well-being to their home address. After
the third appointment, a similar booklet
was sent again and returned to the re-
search team. Parent data will be reported
elsewhere.
Physical and psychosocial well-being.
Physical and psychosocial well-being of
the adolescents was measured using the
87-item child report version of the Child
Health Questionnaire (CHQ) (CHQ-
CF87), covering domains of physical,
emotional, social, and mental health,
rated over the previous 4 weeks (12).
Scores are standardized to 0–100, with
higher scores indicating better well-
being.
Depression. Depressive symptomatol-
ogy was assessed with the 20-item Center
for Epidemiological Studies scale for De-
pression (CES-D) (13). Items are scored
on the basis of frequency of depressive
symptoms reported in the past week,
from 0 (never) to 3 (daily). Total CES-D
scores range between 0 (no depressive
symptoms) to 60 (most frequent/severe
depressive symptoms).
Diabetes-speciﬁc family conﬂict. As
previous studies have shown that family
conﬂicts contribute to poor well-being
andglycemiccontrol(14,15),wedecided
to assess the amount of Diabetes-speciﬁc
familyconﬂictswiththerevisedversionof
the Diabetes-Speciﬁc Family Conﬂict
Scale (DFCS). The DFCS assesses the
degree of family conﬂict on 19 manage-
ment tasks, rated on a 3-point scale (14).
Scores range from 19 (minimum) to 57
(maximum).
Satisfaction with care. The Patients’
EvaluationoftheQualityofDiabetesCare
(PEQ-D) assesses the patients’ judgment
about the quality of diabetes care over the
past 12 months (16). An example item is
“the clarity of the information I receive
from my doctor.” Items are scored on a
ﬁve-point Likert scale and summated to
calculate overall Quality of Care score,
ranging from 0 to 100 (poor to optimal
quality of diabetes care).
Glycemic control. Glycemic control
was assessed by A1C values that were re-
trieved from the charts, using the assess-
ment closest to the date of completion of
the booklets.
Statistical analysis
Scoring and substitution of missing val-
ues was performed according to manuals
(12,17). For the CHQ, in the case of
50% missing data per subscale, substi-
tution of the mean was used. For the
CES-DandDFCS,wesubstitutedmissing
data with the mean if 25% of the data
were missing. None of the patients had
over 25% missing data.
After exploring the change in scores
from baseline to follow-up for each group
with a paired t test or Wilcoxon’s signed-
ranktestincaseofnon-normality,repeated-
measures ANOVA analyses using general
linear modeling in SPSS 14.0 were used.
The effect of the HRQoL intervention was
compared with that of the control group
on physical and psychosocial well-being,
satisfaction with care, and glycemic con-
trol, controlling for baseline levels and
baseline characteristics (age, sex, center,
ethnic minority, family structure, diabe-
tes duration, and treatment regimen).
Multilinear regression analysis was used
to examine the possibility of interaction
and confounding effects of demographic
and diabetes-related variables with the
HRQoL intervention and control group.
First, the effect of the HRQoL inter-
vention on the physical and psychosocial
health summary and subscale scores was
examined, controlling for its baseline
score. In the next step, demographic (sex,
age, center, ethnic minority, and family
structure) and diabetes-related variables
(diabetes duration, A1C, and treatment
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withthegroups,wereaddedtocorrectfor
possible confounders and maintained in
the model if signiﬁcant.
RESULTS— The trial proﬁle is de-
pictedinFig.1.Ofthe171patientsmeet-
ing inclusion criteria, 91 (53%) agreed to
participate. Baseline characteristics of the
study sample have been reported in detail
elsewhere(18).Therewerenodifferences
betweenparticipantsandnonparticipants
insex,age,diabetesduration,orglycemic
control. Ten adolescents (ﬁve in each
group) were lost to follow-up during the
year because of transfer to other diabetes
specialists or no-show. Those who
dropped out had higher A1C levels at
baseline than participants (9.9% vs.
8.7%, P  0.02). There were no other
differences in demographic and psycho-
social variables. The ﬁnal sample con-
tained 81 patients: 41 in the HRQoL
intervention group and 40 in the control
group (Table 1). At baseline, there were
no signiﬁcant differences between the
four clinics or between the HRQoL inter-
vention and control group.
Physical and psychosocial health
Main effects. Physical and psychosocial
well-being scores for the HRQoL inter-
ventionandcontrolgroupatbaselineand
follow-up are shown in the online appen-
dix A1 (available at http://dx.doi.org/
10.2337/dc08-0394).
General linear modeling repeated-
measure analyses with correction for
baseline levels showed a signiﬁcant effect
of group over time for the Psychosocial
health summary scale of the CHQ-CH87
(P  0.006) (Fig. 2A). This effect was
mainlyduetoanimprovementinthesub-
scales Behavior (P  0.007) and Self-
Esteem (P  0.016) for the HRQoL
intervention group, while the scores re-
mained unchanged for the control group.
Interaction effects. Linear regression
analyses with inclusion of the interaction
terms and possible confounders revealed
an interaction effect on the Psychosocial
summary scale between the study groups
and baseline A1C level (R
2  0.382, P 
0.001). For lower A1C levels, scores of
theHRQoLinterventiongroupimproved,
whereas they remained stable in the con-
trol group. Closer inspection of the sub-
scales revealed a signiﬁcant interaction
effect for the subscales Behavior (R
2 
0.562, P  0.001), Mental Health (R
2 
0.404, P  0.001), and Family Activities
(R
2  0.370, P  0.001). For adolescents
with highest A1C values (9.5%), how-
ever, there was no difference between
baseline and follow-up scores in the
HRQoL intervention (or control) group.
For the Self-Esteem subscale, we found
that scores improved for the HRQoL in-
tervention group between baseline and
follow-up,regardlessofA1Cvalues(R
2
0.382, P  0.001).
No differences over time between the
two groups on Physical Health, family
conﬂicts (DFCS), or depression (CES-D)
were observed.
Satisfaction with care
Adolescents in the HRQoL intervention
group reported to be more satisﬁed with
their care (on the PEQ-D) at 1 year fol-
low-up compared with the control group
(P  0.009) (Fig. 2B). This effect was
independent of A1C, demographic, and
diabetes-related variables.
Figure 1—Flow diagram of the participants through each stage of the trial.
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At follow-up, mean A1C was 8.4  1.6%
for the HRQoL intervention group and
8.31.3%forthecontrolgroup,withno
signiﬁcant difference between the groups
in decline in A1C levels over time (P 
0.54).
Post hoc analyses
Change in PedsQL scores in relation to
CHQ and PEQ-D scores at follow-up in
the HRQoL intervention group. To ex-
plore if the changes in PedsQL scores
were related to CHQ-CF87 (well-being)
and PEQ-D (satisfaction with care) scores
at follow-up, we used linear regression
analyses, controlling for baseline CHQ
scores. Change in PedsQL treatment bar-
rier scores were related to change in CHQ
Behavior scores (R
2  0.612, P  0.001;
treatmentbarriers0.218,P0.035),
whereas change in the PedsQL Diabetes
module total score was related to the
CHQ Self-Esteem subscale scores at fol-
low-up (R
2  0.486, P  0.001,  total
diabetes  0.478, P  0.016). Change in
the Emotional subscale scores of the
PedsQL were related to CHQ Mental
health subscale scores at follow-up (R
2 
0.409, P  0.001;  emotional  0.316,
P  0.029).
Change in the PedsQL Psychosocial
summary score (especially the Emotional
andSchoolsubscales)wasassociatedwith
the Family activities subscale of the CHQ
at follow-up (R
2  0.693, P  0.001; 
psychosocial  0.514, P  0.026).
PEQ-D scores at follow-up were not
predicted by change in PedsQL scores,
suggesting that the reported increased
satisfaction with care was independent of
changes in HRQoL.
Predictors of A1C at follow-up. Be-
cause we did not ﬁnd a signiﬁcant change
in glycemic control, we collapsed both
groupstoexplorepredictorsforchangein
A1C levels. In a forward linear regression
analysis, over 20% of the variance in
change in A1C was explained by baseline
A1C levels and amount of family conﬂict
(DFCS scores) (R
2  0.204, P  0.001; 
baseline A1C  0.391, P  0.001; 
DFCS  0.057, P  0.024). A1C ex-
plained 14.7% and DFCS scores ex-
plainedanadditional5.6%ofthevariance
in change.
CONCLUSIONS — This is the ﬁrst
trial to demonstrate the positive effects of
periodic assessment and discussion of
Table 1—Baseline characteristics of participating adolescents by group
HRQoL intervention group Control group
Patients (n)4 1 4 0
Girls/boys (n) 19/22 19/21
Age (years) 14.8  1.1 14.9  1.0
BMI (kg/m
2) 21.1  3.6 21.1  3.0
Diabetes duration (years) 7.2  4.3 6.2  4.3
Injections per day (%)
2 9.8 5
3 51.2 30
4 29.3 45
Pump 9.8 20
A1C (%) 8.6  1.4 8.8  1.3
Single-parent families (n)5 9
Ethnic minority (n)4 5
Data are means  SD unless otherwise indicated. There were no signiﬁcant differences between the HRQoL
intervention and control group.
Figure2—A:CHQPsychosocialHealthsumscoreatbaseline(f)andfollow-up( ).CHQscores
weresimilaratbaselineforthecontrolandHRQoLinterventiongroups.Thefollow-upscoreswere
signiﬁcantly higher for the HRQoL intervention group compared with baseline (P  0.01). B:
PEQ-D scores at baseline (f) and follow-up ( ). PEQ-D scores were similar at baseline for the
control and HRQoL intervention groups. The follow-up scores were signiﬁcantly higher for the
HRQoLinterventiongroupcomparedwithbaseline(P0.01).*P0.001baselinevs.follow-up.
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tes as an integral part of diabetes out-
patient care. At the 1-year follow-up,
patientsintheHRQoLinterventiongroup
reported signiﬁcantly fewer behavioral
problems, improved self-esteem and
mental health, and increased participa-
tion in family activities. The adolescents
in our study reported relatively high lev-
els of well-being at study entry (18), yet
we achieved clinically relevant improve-
ments with effect sizes ranging between
0.36 (moderate) and 0.57 (large).
Whether the same or larger effects can be
establishedinteenagerswithalessfavorable
psychological proﬁle remains to be seen.
Interestingly, we found that adoles-
cents with relatively high A1C values at
baseline (9.5%) did not show improve-
ment (nor worsening) of psychosocial
outcomes over time. This may reﬂect
higher levels of complexity in these ado-
lescents or may be related to how PedsQL
outcomes were discussed. In this group,
pediatricians may be inclined to focus on
the importance of achieving strict glyce-
mic control, putting less emphasis on
psychosocial issues. Unfortunately, we
cannot verify whether such differences in
communication occurred, as we were not
able to record the consultations. Exami-
nation of notes made by the pediatricians
using a checklist conﬁrmed that HRQoL
scoreswerediscussedbasedontheassess-
ment but not how that was done. Future
research should, if possible, include vid-
eotaping to observe the behavior of pedi-
atricians and the interaction with the
adolescent.
The positive effect of the HRQoL in-
tervention on psychosocial well-being
was associated with neither improvement
nor worsening of glycemic control. A1C
levels remained constant in both groups,
in contrast to the often-observed deterio-
ration during puberty. This might be due
to a study effect or a selection bias.
The HRQoL intervention was overall
wellappreciatedbytheadolescents,inde-
pendent of their A1C and whether or not
there was improvement in psychosocial
well-being. Adolescents indicated on the
PEQ-DthatdiscussingHRQoLduringthe
consultation helped the pediatricians to
be more supportive and offered more op-
portunities for shared decision-making.
Moreover, no adverse effects of the mon-
itoring procedure were reported, in con-
cert with previous studies in adult
populations (7,8).
Some limitations of our study need to
bementioned.Selectionbiasmayhaveaf-
fected our results, since about half of the
eligiblepatientsdecidednottoparticipate
in the registered clinical trial. Previous
studies in the adolescent population also
showed large refusal rates (19,20). Poor
glycemic control was obviously not a rea-
son for decline, and the variation among
individual adolescents in physical and
psychosocialwell-beingwasquitelarge.It
is of note that the adolescents who
dropped out of the study did have higher
A1C levels at baseline compared with the
others.
Another limitation is the fact that we
did not assess self-care behavior. We can
therefore not exclude the possibility that
minor changes in self-management have
occurred,althoughitisunlikelygiventhe
stable A1C in both groups. In contrast to
our expectation, the HRQoL intervention
did not affect glycemic control. We
shouldacknowledgethefactthatdiscuss-
ing HRQoL issues does not necessarily
leadtotalkingaboutdiabetesmismanage-
ment (e.g., insulin omission) and indeed
pediatricians were not instructed to do so
inourstudy.Itwouldseemworthwhileto
test if adding a more focused assessment
and discussion of self-care, using a goal-
directed “conversation map,” facilitates
behavior change with subsequent im-
provements in glycemic control (19).
In line with previous studies, family
functioning, along with baseline A1C,
proved to be an important determinant of
glycemic control at follow-up, with those
having fewer family conﬂicts showing
betteroutcomes(14,21).ThePedsQLhas
good psychometric properties and utility
(22), but it contains only one question on
familyfunctioning.Expandingtheassess-
ment of family functioning as part of pe-
riodic monitoring and discussion of
HRQoL in teenagers with diabetes should
therefore be considered.
Basedonatwo-tothreefoldincreased
rate of depression among teenagers
with diabetes (23,24), screening for con-
current emotional problems is recom-
mendedinthisage-group(5,6).However,
in our study, only three patients reported
CES-D scores indicative of depression.
Future studies should determine if the
PedsQL is suitable as a screener for de-
pressive symptoms in adolescents or
whether an additional depression
screenerisneeded.Inmoregeneralterms,
further research is needed to test whether
systematic monitoring and discussion of
HRQoL can effectively help to detect psy-
chological problems at an early stage,
thereby preventing further deterioration.
Little is known about the optimal fre-
quency of monitoring HRQoL. The posi-
tive results in our study were achieved by
monitoring and discussing HRQoL every
3 or 4 months, linked to routine outpa-
tient visits. Further research should test
whether less frequent monitoring, for ex-
ample on an annual basis, produces the
same outcomes across different patient
groups.
In sum, implementing a computer-
assisted HRQoL intervention in routine
pediatric diabetes care is feasible, well ap-
preciated by adolescents and providers,
andresultsinsigniﬁcantimprovementsin
psychosocial well-being.
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